Delivery Order SPE2DB22D3004-SPE2DB25FSH75
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,297.25 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lidocaine 5% Patch 30s. This competitively awarded contract, utilizing firm fixed pricing with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $3,576.20 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s on September 19, 2025, with an ultimate completion date of September 22, 2025. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lidocaine 5% Patch 30S, a topical pain relief medication. This firm fixed price delivery order, valued at $12.3K, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December 2026. The award was made on a competitive, non-set-aside...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,474.64 for Lidocaine 5% Patch (30-count) on September 18, 2025, with completion targeted for September 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $12.76K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lidocaine 5% Patch 30S, with performance completion scheduled for September 9, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement designated SPE2DX and running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lidocaine 5% Patch (30-count units) under a firm fixed-price arrangement with a ceiling value of $1,412.04. The contract, which is not set-aside and was competitively awarded, represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This underlying prime IDV, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $13,980.28. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Lidocaine 5% patches (30-count units) with a ceiling value of $2,734.80. This is a firm fixed price, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units on July 24, 2025, with a ceiling value of $12,221.66 and a firm fixed price structure. The delivery order represents a competitive award with no set-aside designation and is set for completion by July 25, 2025. This award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,418.56 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSH75Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.04 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Lidocaine 5% Patch 30s. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is expected to be completed by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order, this delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's DLA prime contract vehicle enables comprehensive pharmaceutical and medical supply support across multiple therapeutic domains, positioning it to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This specific delivery order for topical pain management medication reflects the company's role in fulfilling routine medical supply needs within the broader pharmaceutical prime vendor program supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/5/25 |